Masimo Corporation (MASI) is a publicly traded Healthcare sector company. As of May 20, 2026, MASI trades at $178.81 with a market cap of $9.36B and a P/E ratio of -63.18. MASI moved +0.01% today. Year to date, MASI is +33.43%; over the trailing twelve months it is +14.48%. Its 52-week range spans $125.94 to $194.88. Analyst consensus is neutral with an average price target of $180.00. Rallies surfaces MASI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Masimo Reports <1% Bias in Newborn Pulse Oximetry, Zero Occult Events in Black, Hispanic Infants: Masimo demonstrated less than 1% overall bias in its SET pulse oximetry readings across 136 paired SpO2-SaO2 measurements from 70 critically ill newborns, with only one occult hypoxemic event observed in a light-skinned patient. No clinically significant skin pigmentation-related discrepancies occurred among Black or Hispanic infants.
| Metric | Value |
|---|---|
| Price | $178.81 |
| Market Cap | $9.36B |
| P/E Ratio | -63.18 |
| EPS | $-2.83 |
| Dividend Yield | 1.00% |
| 52-Week High | $194.88 |
| 52-Week Low | $125.94 |
| Volume | 703.10K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.53B |
| Net Income | $-151.50M |
| Gross Margin | 61.90% |
3 analysts cover MASI: 0 strong buy, 0 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $180.00.